RET and multiple endocrine neoplasia type 2: Although the large majority of cases are sporadic, up to 25% of MTC disclose a genetic predisposition, due to a germline RET gene mutation, which also drives other endocrinological tumours in the framework of the syndrome Multiple Endocrine Neoplasia type 2 (MEN2) (1).